Correction of murine ADAMTS13 deficiency by hematopoietic progenitor cell–mediated gene therapy

ADAMTS13, a metalloprotease primarily synthesized in liver and endothelial cells, cleaves von Willebrand factor (VWF) at the central A2 domain, thereby reducing the sizes of circulating VWF multimers. Genetic or acquired deficiency of plasma ADAMTS13 activity leads to a potentially fatal syndrome, t...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Laje, Pablo, Shang, Dezhi, Cao, Wenjing, Niiya, Masami, Endo, Masayuki, Radu, Antoneta, DeRogatis, Nicole, Scheiflinger, Friedrich, Zoltick, Philip W., Flake, Alan W., Zheng, X. Long
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: American Society of Hematology 2009
Onderwerpen:
Gene Therapy
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2652365/
https://ncbi.nlm.nih.gov/pubmed/19141866
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2008-08-173021
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items